NASDAQ · PBAX
Phoenix Biotech Acquisition Corp.
Financial Services · Shell Companies
$5.85
Up+$0.37 (+6.75%)
Updated Aug 25, 2026, 10:36 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 36.47M
- P/E ratio
- -0.13
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 6.12K
- Avg. volume
- 8.08K
Price performance
PBAX price history
1M range · 0 trading sessions · Daily adjusted prices
PBAX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest PBAX news
The latest Smart Investors Daily articles mentioning PBAX.
Stock researchCompany · Overview
PBAX research
Overview
Company profile and research snapshot.
Company profile
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
